| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +33% |
| 3Y CAGR | +22% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +99% |
| 3Y CAGR | +33% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,740.40 0.00 (--) | 21,702.50 | 29.52 | 5.16 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,540.70 0.00 (--) | 19,323.31 | 28.5 | 5.39 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,136.00 0.00 (--) | 17,802.75 | 104.95 | 20.4 | ||
Natco PharmaNATCOPHARM | ₹857.60 0.00 (--) | 15,371.21 | 13.43 | 1.67 |